Microba Life Sciences Health Care

$0.300 -0.015 (-4.76%)

High $0.31	Low $0.30	Trades 7	Turnover $48,780	Volume 160,000
30 June 2023 at 4:10pm

Register to track MAP and receive email alerts.

Market Cap (1-Jul) $43,777,552 (0th)	Close (30-Jun) $0.300 0 (0%)	Volume (30-Jun) 160,000	Shortsold (19-Jun) 3,649,691 (0.81%) (242nd)
52w High $0.325	52w Low $0.082	P/E -	EPS -0.03

	Subject
	MAP MAP Ann: Proposed issue of securities - MAP
	1 (current) 2 3
	MAP MAP Ann: Sonic Investment & Partnership Investor Presentation
	MAP MAP Ann: Sonic Acquires 19.9% Microba Stake and Enters Partnership
	MAP MAP Ann: Trading Halt
	MAP MAP Ann: Results of AGM
	MAP MAP Ann: 2022 AGM Presentations
	MAP MAP Ann: Change of Director's Interest Notice - Pasquale Rombola
	MAP MAP Ann: Change of Director's Interest Notice - Prof Ian Frazer
	MAP MAP Ann: Microba receives $2.62m R&D Tax Incentive refund
	MAP MAP Ann: Investor Presentation Q1 FY23 Update
	MAP MAP Ann: Details of Q1 FY23 Investor Webinar
	MAP MAP Ann: Q1 FY23 Quarterly Activities Report & Appendix 4C
	MAP MAP Ann: Change in substantial holding - Tiga Trading Pty Ltd
	MAP MAP Ann: Change in substantial holding from TEK
	MAP MAP Ann: Annual Report to Shareholders
	MAP MAP Ann: Letter to Shareholders, Notice of AGM & Proxy Form
	MAP MAP Ann: Change in substantial holding
	MAP MAP Ann: Microba, SYNLAB Extend & Expand Distribution
	MAP MAP Ann: Ceasing to be a substantial holder
	MAP MAP Ann: Investor Presentation October 2022
	MAP MAP Ann: Date of AGM and Closing Date for Director Nominations
	MAP MAP Ann: Release of Restricted Securities
	MAP MAP Ann: Initial Director's Interest Notice - Jacqueline Fernley
	MAP MAP Ann: Director Appointment - Jacqueline Fernley
	MAP MAP Ann: Becoming a substantial holder - Tiga Trading Pty Ltd
	MAP MAP Ann: Becoming a substantial holder from TEK
	MAP MAP Ann: Change in substantial holding
	MAP MAP Ann: Therapeutic Program Advancement
	MAP MAP Ann: Investor Presentation - FY22 Update Annual Results
	MAP MAP Ann: Appendix 4G
	MAP MAP Ann: Corporate Governance Statement
	MAP MAP Ann: Appendix 4E & Annual Report
	MAP MAP Ann: Change in substantial holding
	MAP MAP Ann: Change in substantial holding
	MAP MAP Ann: Microba receives two AusIndustry Advanced Overseas Findings
	MAP MAP Ann: Investor Update - Q4 FY22 Results
	MAP MAP Ann: Q4 FY22 Quarterly Activities Report & Appendix 4C
	MAP MAP Ann: Details of Q4 FY22 Investor Webinar
	MAP MAP Ann: Global Leader IFF and Microba Reach First Milestone
	MAP MAP Ann: Genova Diagnostics Partnership Commences in the US
	MAP MAP Ann: G42 Healthcare Partnership Commences Operation
	MAP MAP Ann: Next Generation Product Released to Health Professionals
	MAP MAP Ann: Application for quotation of securities - MAP
	MAP MAP Ann: Microba & Ginkgo Commence Therapeutics Program
	MAP MAP Ann: Release of Restricted Securities from Escrow
	MAP MAP Ann: Microba Appoints CRO for IBD Clinical Trial
	MAP MAP Ann: Partnership signed with nib-backed Midnight Health
	MAP MAP Ann: Change in substantial holding
	MAP MAP Ann: Microba Appoints Senior US Sales Lead
	MAP MAP Ann: Microba Accelerates Cancer Program

Register to track MAP and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
30-Jun	$0.09	412,727	0.00 (2.30%)
27-Jun	$0.09	437,751	+0.00 (3.57%)
26-Jun	$0.08	1,857,205	-0.01 (6.67%)
24-Jun	$0.09	1,324,453	0.00 (0.00%)
23-Jun	$0.09	338,928	-0.03 (21.74%)
20-Jun	$0.12	0	0.00 (0.00%)
19-Jun	$0.12	0	0.00 (0.00%)
18-Jun	$0.12	28,810	0.00 (4.17%)
16-Jun	$0.12	218,550	-0.01 (4.00%)
13-Jun	$0.13	45,323	-0.01 (3.85%)
12-Jun	$0.13	224,436	+0.01 (8.33%)
06-Jun	$0.12	437,740	-0.01 (4.00%)
05-Jun	$0.13	354,172	-0.01 (3.85%)
04-Jun	$0.13	894,008	-0.02 (10.34%)
03-Jun	$0.15	281,876	0.00 (0.00%)
2 up, 9 down, and 4 flat days